Read more
10:49 ยท 13 May 2026

OIL: EIA points to a deeper supply shock than expected ๐Ÿ”Ž

Oil prices remain highly sensitive to developments in the Middle East, with Brent and WTI still holding around 100 USD per barrel despite a slight pullback today. The market continues to be supported by ongoing disruptions around the Strait of Hormuz, where the blockade is still restricting a significant portion of global supply. Prices started to edge lower after three consecutive days of gains, as investors looked for greater clarity regarding the fragile ceasefire and the upcoming Trump–Xi summit in China.

The latest EIA forecasts point to a much deeper and longer-lasting supply shock than previously expected. The agency now assumes that the Strait of Hormuz will remain effectively closed until the end of May, with Middle Eastern oil supply losses peaking at around 10.8 million barrels per day this month. As a result, global inventories are expected to decline by 2.6 million barrels per day this year, a significantly larger draw than in previous forecasts. The EIA expects Brent to average around 106 USD per barrel in May and June before easing toward 89 USD in the fourth quarter as regional production gradually recovers. At the same time, the agency warns that if disruptions persist for one additional month, prices could temporarily rise by another 20 USD per barrel.

At the same time, high prices are increasingly weighing on the demand outlook. The EIA cut its forecast for global oil demand growth to just 200 thousand barrels per day this year from the previous 600 thousand, citing demand destruction caused by high energy costs. More expensive fuel is already translating into broader inflation concerns, complicating the outlook for consumers, central banks, and the US economy.

 

13 May 2026, 21:46

Daily Summary: Hot inflation and awaiting for news from Beijing

13 May 2026, 18:56

US OPEN: Higher inflation to cap gains?

13 May 2026, 15:52

Market Wrap: Bulls return to Wall Street (13.05.2026)

12 May 2026, 21:31

Daily Summary: Wall Street Under Pressure After Highest Inflation Reading Since 2023

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.